{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P01308",
      "entity_text" : "insulin",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:5281239",
      "entity_text" : "fucoxanthin",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "XREF_BIBR, XREF_BIBR In several in vivo animal studies, fucoxanthin supplementation was shown to reduce blood glucose, plasma insulin, body weight gain, and accumulation of lipid in the liver; to decrease insulin resistance; and to improve the plasma lipid profile.",
  "reading_complete" : "2020-08-03T11:02:24Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T10:58:44Z",
  "trigger" : "reduce",
  "evidence" : [ "fucoxanthin supplementation was shown to reduce blood glucose, plasma insulin" ],
  "pmc_id" : "6551690",
  "score" : 0
}